YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Teva to buy U.S. drug developer Auspex for $3.5B

Posted online
Israel's Teva Pharmaceutical Industries said it would buy U.S. drug developer Auspex Pharmaceuticals Inc. for $3.5 billion to boost its portfolio of treatments for the central nervous system.

The world's largest maker of generic drugs, Teva announced it will offer $101 per share in cash, representing a 42.4 percent premium on Auspex's Friday closing price.

The deal is expected to be finalized by 2017.

Read more from Reuters.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Letter to the Editor: No half-baked cake for our kids. No half-baked school grades, either.

Nixa Superintendent Gearl Loden weighs in on A-F grade cards.

Most Read
Update cookies preferences